Shaver et al. discovered that serum APN levels in DCM patients were lower than in diabetic patients alone and significantly lower than in normal controls, implying that clinical APN levels can be used to monitor early cardiomyopathy in diabetic patients [16]. The gene discussed is ANPEP; the disease is familial dilated cardiomyopathy.